UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000021419
Receipt No. R000024699
Official scientific title of the study Investigation of adverse events in long-term administration of vonoprazan for patients with gastroesophageal reflux disease
Date of disclosure of the study information 2016/03/10
Last modified on 2017/02/03 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Investigation of adverse events in long-term administration of vonoprazan for patients with gastroesophageal reflux disease
Title of the study (Brief title) Investigation of adverse events in long-term administration of vonoprazan
Region
Japan

Condition
Condition Gastroesophageal reflux disease
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Investigation of adverse events in
long-term administration of vonoprazan for patients with gastroesophageal reflux disease.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Incidence of malignant tumor.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
99 years-old >=
Gender Male and Female
Key inclusion criteria Patients with gastroesophageal reflux disease having possibility of taking vonoprazan for long-term.
Key exclusion criteria The patients having contraindication of vonoprazan administratioon.
Target sample size

Research contact person
Name of lead principal investigator Hisatsugu Noda
Organization Aichi medical university school of medicine
Division name gastroenterology
Address 1-1 Yazakokarimata, Nagakute, Aichi, Japan
TEL 0561-62-3311
Email bisaipan@aichi-med-u.ac.jp

Public contact
Name of contact person Hisatsugu Noda
Organization Aichi medical university school of medicine
Division name gastroenterology
Address 1-1 Yazakokarimata, Nagakute, Aichi, Japan
TEL 0561-62-3311
Homepage URL
Email bisaipan@aichi-med-u.ac.jp

Sponsor
Institute Aichi medical university school of medicine
Institute
Department

Funding Source
Organization Aichi medical university school of medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 10 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2016 Year 03 Month 09 Day
Anticipated trial start date
2016 Year 03 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Cohort study

All the members who were equal to criteria for selection in the patients who consulted our institution in March, 2019 from March, 2016

Management information
Registered date
2016 Year 03 Month 10 Day
Last modified on
2017 Year 02 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024699